How do wrong words get into a safety labeling change?

Usually against a deadline. Section 505(o)(4) of the FD&C Act lets the FDA require an application holder to add new safety information to its labeling, and the holder has a short window to respond. New safety text written fast, set into an existing label and then carried into other labeling is a classic spot for a correctly spelled wrong word.

This page is general information, not legal or regulatory advice.

What a safety labeling change is

The FDA's current draft guidance on safety labeling changes (September 2025) says section 505(o)(4) authorizes the FDA to require application holders for certain drugs to make labeling changes based on new safety information, including information related to reduced effectiveness, that becomes available after approval. The draft says it will replace the July 2013 final guidance once it's finalized. As of October 2026, the FDA lists it as a draft, not for implementation.

The draft says the new safety information can be described in any section of the Prescribing Information, or in other prescription drug labeling such as FDA-approved patient labeling and carton or container labeling.

Who writes the wording, and the clock

The draft guidance says the FDA's notification letter generally includes proposed labeling changes. The draft says the application holder must then either submit a supplement with proposed labeling changes or submit a rebuttal statement explaining why a change isn't warranted, within 30 days. The draft says the FDA reads that as 30 calendar days from the date the letter is issued. The draft says changes to the language or placement of the proposed text can happen during discussion periods with the application holder.

Why new safety text attracts wrong words

Our view: several things stack up. The text is new, so nobody has read it many times. It's written or edited against a deadline. And it often lands in several documents at once, so a fix in one can miss another.

Made-up example: new safety text for a warning should say "dysphagia" (difficulty swallowing) but the patient labeling version says "dysphasia" (difficulty with language). The Prescribing Information is correct, so a reviewer who checks only that document passes it.

Why spellcheck misses it

Both words are real and spelled correctly. Spellcheck passes them, and a tracked-changes review shows only that text changed, not whether it means what it should.

What to check next

Practice advice:

• List each document the new text lands in, including patient labeling and carton or container labeling where it applies.
• Read the new text in each one for meaning, side by side, before you submit.
• Check any edits made during a discussion period the same way. Late changes get the least reading.
• For how a fix is submitted afterwards, see label typo: supplement or annual report.

This is our reading of public guidance, not legal or regulatory advice.

Sources

• FDA: Safety Labeling Changes—Implementation of Section 505(o)(4) of the FD&C Act (draft guidance, September 2025)
• FDA: Safety Labeling Changes draft guidance (PDF)

Last reviewed: October 18, 2026

More on contextual errors in FDA DailyMed labels.

Questions about wording on your own labels? Talk to us.

We scan freshly published FDA DailyMed labels every day and pull out these high-stakes wrong words.

Every Tuesday and Friday, a new case like this lands in your inbox if you subscribe.

What is a safety labeling change?

Section 505(o)(4) of the FD&C Act lets the FDA require certain application holders to add new safety information that becomes available after approval to their drug's labeling.

Who writes the wording for a safety labeling change?

The FDA's notification letter generally includes proposed labeling changes. The application holder then submits a supplement with proposed changes, or a rebuttal statement, and the FDA reviews it.

How long does an application holder have to respond?

The FDA's draft guidance says the supplement or rebuttal statement must be submitted within 30 days, which the FDA reads as 30 calendar days from the date the letter is issued.

Is the FDA's safety labeling change guidance final?

The current version is a draft from September 2025. When finalized, it will replace the July 2013 guidance.

How do I check new safety wording before submitting?

Practice advice: read each spot where the new text appears, such as the Prescribing Information and patient labeling, for meaning, side by side.